{"id":194,"date":"2026-04-11T01:53:34","date_gmt":"2026-04-11T01:53:34","guid":{"rendered":"https:\/\/huavi.pe\/blog\/medvi-ai-powered-drug-marketing-raises-ethical-concerns-after-new-york-times-profile-sparks-backlash\/"},"modified":"2026-04-11T01:53:34","modified_gmt":"2026-04-11T01:53:34","slug":"medvi-ai-powered-drug-marketing-raises-ethical-concerns-after-new-york-times-profile-sparks-backlash","status":"publish","type":"post","link":"https:\/\/huavi.pe\/blog\/medvi-ai-powered-drug-marketing-raises-ethical-concerns-after-new-york-times-profile-sparks-backlash\/","title":{"rendered":"Medvi: AI-Powered Drug Marketing Raises Ethical Concerns After New York Times Profile Sparks Backlash"},"content":{"rendered":"<p><div style=\"margin: 35px 0; text-align: center;\">\r\n        <script type=\"text\/javascript\">atOptions = {\"key\":\"2d383bfb6047810e1afc5176a93a6e27\",\"format\":\"iframe\",\"height\":90,\"width\":728,\"params\":{}};<\/script>\r\n        <script type=\"text\/javascript\" src=\"https:\/\/www.highperformanceformat.com\/2d383bfb6047810e1afc5176a93a6e27\/invoke.js\"><\/script>\r\n    <\/div>The pharmaceutical marketing company Medvi, hailed by the New York Times as a groundbreaking venture poised to surpass one billion dollars in revenue, has been embroiled in controversy following its recent profile. The article, which lauded Medvi&#8217;s innovative use of AI for business growth, sparked immediate online backlash over the ethical implications of the company&#8217;s practices.  Medvi operates as a marketing wrapper for telehealth companies that prescribe and fulfill orders for GLP-1 agonists and other compounded drugs, using deceptive tactics to mislead consumers. The company has been accused of fabricating before-and-after client photos with AI, falsely claiming media coverage from mainstream outlets, and utilizing the likeness of medical practitioners without their consent.  These allegations were largely ignored in the NYT&#8217;s profile, which downplayed or omitted these ethical red flags.<div style=\"margin: 35px 0; text-align: center;\">\r\n        <script type=\"text\/javascript\">atOptions = {\"key\":\"2d383bfb6047810e1afc5176a93a6e27\",\"format\":\"iframe\",\"height\":90,\"width\":728,\"params\":{}};<\/script>\r\n        <script type=\"text\/javascript\" src=\"https:\/\/www.highperformanceformat.com\/2d383bfb6047810e1afc5176a93a6e27\/invoke.js\"><\/script>\r\n    <\/div><\/p>\n<div style=\"text-align: center; margin: 35px 0;\"><a href=\"https:\/\/www.profitablecpmratenetwork.com\/p4sabm91d?key=88da7d0446f20952699e10bf89600177\" target=\"_blank\" style=\"background: var(--accent); color: #fff; padding: 14px 28px; border-radius: 50px; text-decoration: none; font-weight: 700; font-size: 0.85rem; display: inline-block; box-shadow: 0 4px 15px rgba(0,85,255,0.2);\">Descubrir contenido premium ahora<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The pharmaceutical marketing company Medvi, hailed by the New York Times as a groundbreaking venture poised to surpass one billion dollars in revenue, has been embroiled in controversy following its recent profile. The article, which lauded Medvi&#8217;s innovative use of AI for business growth, sparked immediate online backlash over the ethical implications of the company&#8217;s [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":195,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[256],"tags":[271,287,288,272,270,166],"class_list":["post-194","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-disrupcion","tag-ai","tag-drug-marketing","tag-ethics","tag-telehealth","tag-medvi","tag-global"],"_links":{"self":[{"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/posts\/194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/comments?post=194"}],"version-history":[{"count":0,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/posts\/194\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/media\/195"}],"wp:attachment":[{"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/media?parent=194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/categories?post=194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/huavi.pe\/blog\/wp-json\/wp\/v2\/tags?post=194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}